Breaking News: Johan Rojas' Positive Drug Test Shakes Up Phillies' Outfield Plans
In a shocking development, Phillies outfielder Johan Rojas has reportedly tested positive for a performance-enhancing drug, as reported by Wilber Sánchez and Jon Heyman. This news has sent shockwaves through the baseball world, leaving fans and analysts alike wondering about the implications for Rojas and the Phillies.
Rojas, a 25-year-old speedster, has been a key part of the Phillies' outfield rotation for the past three seasons. Known for his defensive prowess and base-stealing abilities, Rojas has been a valuable asset to the team. However, his lack of offensive production has been a concern, with a batting line of just .252/.294/.340 and a wRC+ of 74, indicating he has struggled at the plate.
Despite his defensive skills, Rojas' limited offensive output has impacted his playing time. He was an everyday center fielder in 2024, but the Phillies acquired Harrison Bader at the deadline in 2025, pushing Rojas to the minors for the final stretch of the season. With Bader now a free agent, the Phillies seemed to be moving on from Rojas, as they planned to give prospect Justin Crawford a chance in center field.
But here's where it gets controversial... Rojas, who has an option remaining, was likely headed for a fourth outfielder role or a demotion to Triple-A for regular playing time. However, a potential 80-game suspension for his positive PED test would significantly impact his ability to contribute in either capacity. Heyman reports that Rojas intends to appeal the ruling, but the outcome remains uncertain.
And this is the part most people miss... While Rojas may not have been a prominent piece of the Phillies' 2026 plans, his absence would still be felt. The Phillies have a strong roster, but their outfield is a potential weak spot. Crawford, with no major league experience, is set to take over center field. Adolis García, hoping for a bounce-back year, is in right field, while Brandon Marsh, who needs a platoon partner against lefties, patrols left field. Otto Kemp, with more experience at infielder, could be Marsh's partner.
The Phillies' 40-man roster also includes Gabriel Rincones Jr. and Pedro León, both with options to start in the minors. Rincones is currently dealing with knee problems, while León has limited big league experience. Bryan De La Cruz, with a disappointing slash line last year, is in camp as a non-roster invitee.
The Phillies' outfield depth is already thin, and losing Rojas would further weaken their options. If the Phillies want to bolster their outfield before Opening Day, free agents like Tommy Pham and Andrew McCutchen could be potential targets. With spring training winding down, more players will become available as teams finalize their rosters.
This situation raises important questions: Should the Phillies stand by Rojas during his appeal process, or should they move on and address their outfield needs? Is Rojas' positive test an isolated incident, or does it indicate a larger issue within the sport? What impact will this have on the Phillies' 2026 season and their chances of success?
Share your thoughts in the comments! Do you think the Phillies should support Rojas or make a move for a new outfielder? Is this an opportunity for a young prospect to step up, or a sign that the Phillies need to make a significant acquisition?
